US Patent 11925679 H3.3 CTL peptides and uses thereof

Is a

Patent

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

119256790

Patent Inventor Names

Hideho Okada0

Yafei Hou0

Date of Patent

March 12, 2024

Patent Application Number

170778060

Date Filed

October 22, 2020

Patent Citations

‌

US Patent 10849965 H3.3 CTL peptides and uses thereof

‌

US Patent 10202640 Single cell analysis of T cells using high-throughput multiplex amplification and deep sequencing

‌

US Patent 10441644 H3.3 CTL peptides and uses thereof

‌

US Patent 7718776 Human anti-OPGL neutralizing antibodies as selective OPGL pathway inhibitors

‌

US Patent 8119772 MART-1 T cell receptors

‌

US Patent 8652462 Immune regulation

‌

US Patent 9388213 Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof

‌

US Patent 10117918 Antigen-specific T cell receptors and T cell epitopes

Patent Primary Examiner

CPC Code

...

Patent abstract

Peptides that generate an immune response to glioma-related H3.3 proteins and methods of their use are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11925679 H3.3 CTL peptides and uses thereof

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11925679 H3.3 CTL peptides and uses thereof